Total planned funding: $85,199,027
Clear active filters
U.S. Department of State
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $15,013,799 |
Ethiopia | $14,034,367 |
South Africa | $8,916,460 |
Botswana | $8,399,596 |
Mozambique | $8,009,314 |
Uganda | $6,382,134 |
Guyana | $4,272,269 |
Namibia | $4,195,510 |
Ukraine | $3,845,060 |
Zambia | $2,797,416 |
Kenya | $2,450,387 |
Malawi | $2,364,522 |
Democratic Republic of the Congo | $918,000 |
Nigeria | $671,250 |
Eswatini | $615,000 |
Zimbabwe | $503,000 |
Ghana | $492,000 |
Lesotho | $450,000 |
Haiti | $373,943 |
Côte d'Ivoire | $269,010 |
Cameroon | $110,990 |
Rwanda | $50,000 |
Angola | $40,000 |
Vietnam | $25,000 |
Papua New Guinea | $0 |
Organizational Types
Other USG Agency | $68,849,160 |
Own Agency | $10,712,746 |
Implementing Agency | $5,637,121 |
Program Areas
Governance and Systems | $22,558,362 |
Treatment | $21,651,123 |
Care | $14,045,909 |
Prevention | $11,462,875 |
Management and Operations | $11,008,066 |
Testing | $1,379,848 |
Budget Codes
HTXS: Treatment: Adult Treatment | $21,415,594 |
HLAB: Laboratory Infrastructure | $15,390,999 |
HVMS: Management and Operations | $11,008,066 |
HKID: Care: Orphans and Vulnerable Children | $8,749,025 |
OHSS: Health Systems Strengthening | $6,601,319 |
HMBL: Biomedical Prevention: Blood Safety | $4,687,720 |
HBHC: Care: Adult Care and Support | $3,214,807 |
HVOP: Sexual Prevention: Other Sexual Prevention | $2,843,919 |
HVTB: Care: TB/HIV | $1,892,804 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,802,406 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $1,518,055 |
HVCT: Testing: HIV Testing and Counseling | $1,379,848 |
HVSI: Strategic Information | $566,044 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $508,809 |
PDCS: Care: Pediatric Care and Support | $189,273 |
PDTX: Treatment: Pediatric Treatment | $157,655 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $91,395 |
HTXD: Treatment: ARV Drugs | $77,874 |
HMIN: Biomedical Prevention: Injection Safety | $10,571 |
Top Partner Programs
U.S. Department of State:
$85,199,027
View countries